Literature DB >> 17634910

[Interdisciplinary networking for clinical and molecular questions in non-muscle invasive urothelial carcinoma of the bladder].

S Denzinger1, A Hartmann, F Hofstaedter, R Knuechel, P J Wild, D Zaak, C Stief, W F Wieland, R Stoehr, M Burger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17634910     DOI： 10.1007/s00120-007-1458-7

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  18 in total

1.  Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.

Authors:  Ellen C Obermann; Stefanie Meyer; Dorothea Hellge; Dirk Zaak; Thomas Filbeck; Robert Stoehr; Ferdinand Hofstaedter; Arndt Hartmann; Ruth Knuechel
Journal:  Oncol Rep       Date:  2004-04       Impact factor: 3.906

2.  Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis.

Authors:  Stefan Tritschler; Sonja Scharf; Alexander Karl; Derya Tilki; Ruth Knuechel; Arndt Hartmann; Christian G Stief; Dirk Zaak
Journal:  Eur Urol       Date:  2006-08-15       Impact factor: 20.096

3.  Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.

Authors:  Peter J Wild; Alexander Herr; Christoph Wissmann; Robert Stoehr; Andre Rosenthal; Dirk Zaak; Ronald Simon; Ruth Knuechel; Christian Pilarsky; Arndt Hartmann
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

4.  Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.

Authors:  Johanna M M van Oers; Christoph Adam; Stefan Denzinger; Robert Stoehr; Simone Bertz; Dirk Zaak; Christian Stief; Ferdinand Hofstaedter; Ellen C Zwarthoff; Theodorus H van der Kwast; Ruth Knuechel; Arndt Hartmann
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

5.  RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro.

Authors:  Peter J Wild; Rene C Krieg; Juergen Seidl; Robert Stoehr; Kerstin Reher; Claudia Hofmann; Jari Louhelainen; André Rosenthal; Arndt Hartmann; Christian Pilarsky; Anja K Bosserhoff; Ruth Knuechel
Journal:  Mol Cancer Ther       Date:  2005-04       Impact factor: 6.261

6.  Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.

Authors:  Stefan Denzinger; Kristin Mohren; Ruth Knuechel; Peter J Wild; Maximilian Burger; Wolf F Wieland; Arndt Hartmann; Robert Stoehr
Journal:  Hum Pathol       Date:  2005-12-15       Impact factor: 3.466

7.  Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.

Authors:  Edwin Hungerhuber; Herbert Stepp; Martin Kriegmair; Christian Stief; Alfons Hofstetter; Arndt Hartmann; Ruth Knuechel; Alexander Karl; Stefan Tritschler; Dirk Zaak
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

8.  Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.

Authors:  P J Wild; J Giedl; R Stoehr; K Junker; S Boehm; J M M van Oers; E C Zwarthoff; H Blaszyk; S W Fine; P A Humphrey; L P Dehner; M B Amin; J I Epstein; A Hartmann
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

9.  Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.

Authors:  Peter J Goebell; Thomas Otto; Julia Suhr; Herbert Rübben
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.

Authors:  Stefan Denzinger; Maximilian Burger; Bernhard Walter; Ruth Knuechel; Wolfgang Roessler; Wolf F Wieland; Thomas Filbeck
Journal:  Urology       Date:  2007-04       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.